Format

Send to

Choose Destination
Curr Opin Investig Drugs. 2003 May;4(5):556-65.

Anti-inflammatory activity of neutrophil elastase inhibitors.

Author information

1
Unité de recherche, Hôpital Laval, Institut universitaire de cardiologie et de pneumologie, l'Université Laval, 2725 chemin Sainte-Foy, Sainte-Foy, G1V 4G5, Canada. guy.tremblay@crhl.ulaval.ca

Abstract

Neutrophil elastase is a protease that is involved in the tissue destruction and inflammation that characterize numerous diseases, including hereditary emphysema, chronic obstructive pulmonary disease, cystic fibrosis, adult respiratory distress syndrome, ischemic-reperfusion injury and rheumatoid arthritis. Thus, elastase has been the object of extensive research to develop potent inhibitors that target its destructive and pro-inflammatory action. This review focuses on the anti-inflammatory activity of inhibitors that are currently, or were until recently in development, including purified or recombinantly produced endogenous inhibitors, genetically modified recombinant protein inhibitors and synthetic small-molecule inhibitors.

PMID:
12833649
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center